Market Data 
Markets
Replies to post #209844 on Biotech Values
05/08/17 5:37 PM
On May 3, 2017, the Board of Directors of Aralez Pharmaceuticals Inc. voluntarily agreed to a reduction of their cash retainers as part of the Company’s recently announced cost savings program. Specifically, the non-employee members of the Board have agreed to reduce their annual cash retainers by 50% for the next twelve months.
AI
